Clinical trial
AMS VS MOXI Ketek vs Avelox in AMS
NCT00537563 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AMS VS MOXI Ketek vs Avelox in AMS
- Lead sponsor
- Sanofi
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- September 30, 2003
- Enrollment
- 351 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.